COMMUNIQUÉS West-GlobeNewswire

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2019
16/07/2019
Company Announcement Net sales of DARZALEX ® in the second quarter of 2019 totaled USD 774 million Genmab will receive royalties on worldwide sales from Janssen Biotech, Inc. Copenhagen, Denmark; July 16, 2019 – Genmab [...]
Exactus Inc. Announces Appointment of New Chief Financial Officer
16/07/2019
Seasoned, Strategic Finance Executive Kenneth E. Puzder Joins Exactus Senior Management Team DELRAY BEACH, Fla., July 16, 2019 (GLOBE NEWSWIRE) -- Exactus Inc. (OTCQB: EXDI) – (the “Company”), a healthcare company [...]
CorVel Announces Quarterly Earnings Release Webcast
16/07/2019
IRVINE, Calif., July 16, 2019 (GLOBE NEWSWIRE) -- Event: Quarterly Earnings Release Webcast Hosts: Michael Combs, President and Chief Executive Officer Brandon O’Brien, Chief Financial Officer Date: Tuesday July 30, [...]
Immuron North American revenue surges by 52% in FY19
16/07/2019
Key Highlights: Immuron FY19 revenue surged by 52% in North America, reaching $1.16M. In the USA, FY19 Travelan® sales exceeded the $1M AUD milestone for the first time and grew by +32% to $1.02M AUD. In May 2019, USA [...]
ROSINBOMB Announces Their Patent Pending Flow Channel Technology™ Enabling Mass Production of Solventless Oils and Extracts
16/07/2019
Revolutionary Technology Poised to Disrupt the Multibillion Dollar Extract Market RENO, Nev., July 16, 2019 (GLOBE NEWSWIRE) -- Maverick Technology Solutions (OTC:MVRK), manufacturer of the highly acclaimed ROSINBOMB™ [...]
Epistem licence Hubrecht Organoid Technology to expand pre-clinical toxicology service portfolio
16/07/2019
MANCHESTER, United Kingdom, July 16, 2019 (GLOBE NEWSWIRE) -- Epistem Limited, the UK based pre-clinical and clinical research services company announces the expansion of its in vitro model portfolio by the completion [...]
Transactions in relation to share buyback program
16/07/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]
CellaVision ABs strongest quarter ever with continued growth
16/07/2019
The information was submitted for publication at 08.20 CET on July 16, 2019 April 1–June 31, 2019 Net sales increased by 22% to SEK 112.4 million (91.9). Net sales increased organically by 18% (15). Operating profit [...]
Nicox Announces Completion of Enrollment in NCX 470 Phase 2 Clinical Study with Top-Line Results on Track for Early 4Q 2019
16/07/2019
Press Release Nicox Announces Completion of Enrollment in NCX 470 Phase 2 Clinical Study with Top-Line Results on Track for Early 4Q 2019 July 16, 2019 – release at 7:30 am CET Sophia Antipolis, France Nicox SA ( [...]
Nicox : Recrutement terminé dans l’étude clinique de phase 2 pour le NCX 470 – Premiers résultats attendus au début du quatrième trimestre 2019
16/07/2019
Communiqué de presse Nicox : Recrutement terminé dans l’étude clinique de phase 2 pour le NCX 470 – Premiers résultats attendus au début du quatrième trimestre 2019 16 juillet 2019 – diffusion à 07h30 Sophia Antipolis, [...]
FDA accepts file and accelerates review of Novartis sickle cell disease medicine crizanlizumab (SEG101)
16/07/2019
FDA grants crizanlizumab Priority Review based on Phase II data showing prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease, shortening FDA review to six months from standard ten months Vaso- [...]
Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings Release
15/07/2019
Innovate undertakes succession planning for a chief executive officer Finance team strengthened and well positioned for future growth Second quarter earnings release expected August 8, 2019 RALEIGH, N.C., July 15, 2019 [...]
electroCore Files Registration Statement on Form S-3
15/07/2019
BASKING RIDGE, N.J., July 15, 2019 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has filed a "universal shelf" registration statement on [...]
Eyenovia, Inc. Announces Closing of Public Offering
15/07/2019
NEW YORK, July 15, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print [...]
Conformis Establishes Alliance to Focus on ASC Joint Replacement
15/07/2019
BILLERICA, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]
Cancer Genetics, Inc. Announces Strategic Transactions
15/07/2019
Sale of BioPharma business to Interpace Diagnostics Group, Inc. Clinical services business acquired by siParadigm Diagnostic Informatics Significantly reduces its debt burden and will continue to operate its Discovery [...]
Intuitive Surgical acquires Schölly Fiberoptic’s robotic endoscope business
15/07/2019
SUNNYVALE, Calif. and DENZLINGEN, Germany, July 15, 2019 (GLOBE NEWSWIRE) -- Intuitive (Nasdaq: ISRG), the pioneer and a global leader in robotic-assisted, minimally invasive surgery and manufacturer of da Vinci [...]
Arbutus Announces Preliminary Phase 1a/1b Clinical Trial Results for AB-506, an Oral Capsid Inhibitor in Development for People with Chronic Hepatitis B
15/07/2019
Results demonstrate that AB-506 is a potent capsid inhibitor Phase 1a/1b clinical trial to continue with the enrollment of further cohorts Conference call and webcast scheduled today at 4:45 pm ET WARMINSTER, Pa., July [...]
Repligen Corporation Announces Proposed Public Offerings of $100 million of Common Stock and $250 million of Convertible Senior Notes
15/07/2019
WALTHAM, Mass., July 15, 2019 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN) (“Repligen”) today announced that it has commenced concurrent underwritten public offerings of $100,000,000 in shares of its common [...]

Pages